Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
02/07/2013 | US20130036520 USE OF DIG3 INSECTICIDAL CRYSTAL PROTEIN IN COMBINATION WITH Cry1Ab FOR MANAGEMENT OF RESISTANCE IN EUROPEAN CORNBORER |
02/07/2013 | US20130036519 Compositions and Methods for the Control of Root Lesion Nematode |
02/07/2013 | US20130036518 Organism with altered carotenoid content and method of producing same |
02/07/2013 | US20130036516 Plants having enhanced yield-related traits and method for making the same |
02/07/2013 | US20130036514 Soybean variety a1026436 |
02/07/2013 | US20130036513 Soybean variety a1026256 |
02/07/2013 | US20130036512 Soybean variety a1026366 |
02/07/2013 | US20130036511 Soybean variety a1026437 |
02/07/2013 | US20130036510 Soybean variety a1026434 |
02/07/2013 | US20130036509 Soybean variety a1026419 |
02/07/2013 | US20130036508 Soybean variety a1026417 |
02/07/2013 | US20130036507 Soybean variety a1026415 |
02/07/2013 | US20130036506 Soybean variety a1026413 |
02/07/2013 | US20130036505 Soybean variety a1026402 |
02/07/2013 | US20130036504 Soybean variety a1026397 |
02/07/2013 | US20130036503 Soybean variety a1026361 |
02/07/2013 | US20130036502 Soybean variety a1026344 |
02/07/2013 | US20130036501 Soybean variety a1026335 |
02/07/2013 | US20130036500 Soybean variety a1026332 |
02/07/2013 | US20130036499 Soybean variety a1026330 |
02/07/2013 | US20130036498 Soybean variety d2011912 |
02/07/2013 | US20130036497 Soybean variety a1026311 |
02/07/2013 | US20130036496 Soybean variety s100306 |
02/07/2013 | US20130036495 Soybean variety a1026289 |
02/07/2013 | US20130036494 Soybean variety d2011911 |
02/07/2013 | US20130036493 Soybean variety s100305 |
02/07/2013 | US20130036492 Soybean variety a1026142 |
02/07/2013 | US20130036491 Soybean variety a1026154 |
02/07/2013 | US20130036490 Soybean variety a1026150 |
02/07/2013 | US20130036489 Soybean variety a1026138 |
02/07/2013 | US20130036488 Soybean variety d2011909 |
02/07/2013 | US20130036487 Pepper hybrid svr 11368833 |
02/07/2013 | US20130036486 Bean line fivc6v0999 |
02/07/2013 | US20130036485 Bean line fivc6v0998 |
02/07/2013 | US20130036484 Bean line fivc6v1002 |
02/07/2013 | US20130036483 Bean line fivc6v1001 |
02/07/2013 | US20130036482 Method for assessment of potential for development of dravet syndrome and use thereof |
02/07/2013 | US20130036481 Use of perlecan domain v in treating amyloidogenic disease |
02/07/2013 | US20130035755 Medical device with coating that promotes endothelial cell adherence |
02/07/2013 | US20130035513 Methods and compositions for enhanced production of fatty aldehydes and fatty alcohols |
02/07/2013 | US20130035472 Method of producing transcripts using cryptic splice sites |
02/07/2013 | US20130035403 Cells, nucleic acids, enzymes and use thereof, and methods for the production of sophorolipids |
02/07/2013 | US20130035397 Anti-Viral Compounds |
02/07/2013 | US20130035388 Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic acid synthetic complex |
02/07/2013 | US20130035382 Anti-Viral Compounds |
02/07/2013 | US20130035374 MicroRNA induction of pluripotential stem cells and uses thereof |
02/07/2013 | US20130035373 Treatment of fibroblast growth factor 21 (fgf21) related diseases by inhibition of natural antisense transcript to fgf21 |
02/07/2013 | US20130035372 Treatment of colony-stimulating factor 3 (csf3) related diseases by inhibition of natural antisense transcript to csf3 |
02/07/2013 | US20130035371 Lipid formulated dsrna targeting the pcsk9 gene |
02/07/2013 | US20130035370 Compositions and methods for modulation of lmna expression |
02/07/2013 | US20130035369 Double strand compositions comprising differentially modified strands for use in gene modulation |
02/07/2013 | US20130035349 Pyrazolopyrimidinone kinase inhibitor |
02/07/2013 | US20130035348 Antimetastatic compounds |
02/07/2013 | US20130035345 Solid dispersion formulations and methods of use thereof |
02/07/2013 | US20130035327 Modulators of ATP-Binding Cassette Transporters |
02/07/2013 | US20130035324 Heterocyclic compounds and uses thereof |
02/07/2013 | US20130035304 Small molecules for the modulation of mcl-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders |
02/07/2013 | US20130035287 Transient immortalization |
02/07/2013 | US20130035260 Genes involved in inflammatory bowel diseases and use thereof |
02/07/2013 | US20130035256 Chimeric Polypeptides Useful in Proximal and Dynamic High-Throughput Screening Methods |
02/07/2013 | US20130035241 Key genes, micrornas, other non-coding rnas and combination thereof for identifying and regulating the pluripotent status of cells |
02/07/2013 | US20130035233 Novel herbicide resistance genes |
02/07/2013 | US20130034906 Methods for in vitro oocyte maturation |
02/07/2013 | US20130034905 Method for making culture medium |
02/07/2013 | US20130034904 Culture medium |
02/07/2013 | US20130034903 Method for culturing neural cells using culture medium |
02/07/2013 | US20130034902 Fusion Polypeptides Capable of Activating Receptors |
02/07/2013 | US20130034901 Use of a Proteolytic Enzyme for the Modification of the Cell Surface of a Stem Cell |
02/07/2013 | US20130034900 Reprogrammation of eukaryotic cells with engineered microvesicles |
02/07/2013 | US20130034899 Cell culturing device using electrical responsiveness functional material, cell culturing system including the same, and cell culturing method |
02/07/2013 | US20130034894 Novel allene oxide synthase derived from lemna paucicostata |
02/07/2013 | US20130034878 Chondroitin Synthase, Method for Producing The Same and Method for Producing Saccharide Chain-Extended Chondroitin |
02/07/2013 | US20130034875 Dna construct, and process for production of recombinant cho cell using same |
02/07/2013 | US20130034599 Synthetic nanostructures including nucleic acids and/or other entities |
02/07/2013 | US20130034598 Inhibitors of akt/pkb with anti-tumor activity |
02/07/2013 | US20130034581 Genetically engineered swine influenza virus and uses thereof |
02/07/2013 | US20130034576 Novel adenovirus isolated from titi monkeys |
02/07/2013 | US20130034574 Modified melk peptides and vaccines containing the same |
02/07/2013 | US20130034564 Anti-rsv g protein antibodies |
02/07/2013 | US20130034561 Isolated mammalian monocyte cell genes; related reagents |
02/07/2013 | US20130034559 Targeted Binding Agents Against B7-H1 |
02/07/2013 | US20130034558 Epidermal growth factor receptor variant |
02/07/2013 | US20130034554 Antibodies to il-6 and use thereof |
02/07/2013 | US20130034551 Wnt Antagonists and Methods of Treatment and Screening |
02/07/2013 | US20130034543 Modulating xrn1 |
02/07/2013 | US20130034539 Sr-bi as a predictor of human female infertility and responsiveness to treatment |
02/07/2013 | US20130034528 New methods for isolating tr1 cells |
02/07/2013 | US20130034527 Mitochondrial enhancement of cells |
02/07/2013 | US20130034526 Populations of pancreatic progenitor cells and methods of isolating and using same |
02/07/2013 | US20130034525 Beta iselets-like cells derived from whole bone marrow |
02/07/2013 | US20130034524 Non-Enzymatic Method for Harvesting Adipose-Derived Stromal Cells and Adipose-Derived Stem Cells from Fat and Lipo-Aspirate |
02/07/2013 | US20130034500 Cationic Steroid Antimicrobial Compositions and Methods of Use |
02/07/2013 | CA2843896A1 Collagen 7 and related methods |
02/07/2013 | CA2843386A1 Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct |
02/07/2013 | CA2843373A1 Composition for embryo culture |
02/07/2013 | CA2842954A1 Double-stranded oligonucleotide compounds for treating hearing and balance disorders |
02/07/2013 | CA2842872A1 Recombinant swine influenza virus and uses thereof |
02/07/2013 | CA2842368A1 Switch costimulatory receptors |
02/07/2013 | CA2842092A1 Method for identification and isolation of terminator sequences causing enhanced transcription |
02/07/2013 | CA2841985A1 Metabolic maturation in stem cell-derived tissue cells |